Porphyria Cutanea Tarda

Abstract
A case of porphyria cutanea tarda is presented in which clinical and biochemical remission were associated with the administration of 0.5 gm of chloroquine twice weekly over a seven-month period without adverse effects.

This publication has 0 references indexed in Scilit: